Valuation — not yet established
No valuation for Harpoon Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($100.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Harpoon Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2023 | PIPE | $100.2M | ▮ | ▮ |
| Mar 2023 | Early Stage VC | $25.0M | ▮ | ▮ |
| Nov 2018 | Later Stage VC | $70.0M | ▮ | ▮ |
| May 2017 | Early Stage VC | $25.2M | ▮ | ▮ |
How Harpoon Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Harpoon Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Harpoon Therapeutics raised?
- Harpoon Therapeutics has raised $100.2M in total funding across 4 recorded rounds.
- When did Harpoon Therapeutics last raise?
- Harpoon Therapeutics last raised in Oct 2023 (PIPE), raising $100.2M.